Ephedra Rule Cites Lack Of Safety Data In Vulnerable Subjects
This article was originally published in The Tan Sheet
Executive Summary
Research weighed by FDA in evaluating the safety of ephedrine alkaloid-containing dietary supplements was lacking in subjects that were adequately representative of the broader population, the agency maintains in the 1final rule banning the botanical
You may also be interested in...
Synthetics Stance In NDI Guidance Raises Red Flag For Industry
FDA's draft guidance on new dietary ingredient notifications already is arousing fierce pushback from the supplement industry over what constitutes an NDI and which substances cannot be dietary ingredients at all.
Synthetics Stance In NDI Guidance Raises Red Flag For Industry
FDA's draft guidance on new dietary ingredient notifications already is arousing fierce pushback from the supplement industry over what constitutes an NDI and which substances cannot be dietary ingredients at all.
Synthetics Stance In NDI Guidance Raises Red Flag For Industry
FDA's draft guidance on new dietary ingredient notifications already is arousing fierce pushback from the supplement industry over what constitutes an NDI and which substances cannot be dietary ingredients at all.